Proto Axiom

Brandon Capital's $60m taypayer-funded biotech bets

Brandon Capital has put roughly $60 million of National Reconstruction Fund money into ten biotech companies and warns R&D tax changes would hurt deep tech; portfolio company Myricx Bio went to Novartis.

Also australiatimes.com

Birth rates are plummeting globally — this Australian IVF trial wants to change that

Proto Axiom has put $4 million into Sydney IVF biotech JumpStart Fertility, a UNSW spin-out, to pay for human trials of a treatment aimed at age-related fertility decline.

University of Sydney launches $25 million pre-Seed fund for its home-grown startups

The University of Sydney has launched a $25 million pre-seed fund to back ventures spun out of its research, naming five initial investments across carbon capture, diabetes treatment, inhaled medicines and cardiovascular devices.

FUNDED April 2023

Techboard's monthly roundup counts 40 Australian startup raises worth $498m in April 2023, headlined by Saluda Medical and Eucalyptus, plus smaller rounds and fund closes by Purpose Ventures and Proto Axiom.